There are 2789 resources available
1544P - Soft tissue sarcoma (STS) incidences and clinical characteristics are significantly different between different geographic and ethnic populations
Presenter: Tom Wei-Wu Chen
Session: ePoster Display
1545P - Initial presentation of sarcomas in adult patients from private and public health insurance systems in Brazil: A single center analysis
Presenter: Celso Filho
Session: ePoster Display
1546P - Therapeutic strategies for uterine PEComas
Presenter: Chiara Cimmino
Session: ePoster Display
1547P - Trabectedin in soft-tissue sarcoma patients in Italy: Analysis of real-world data from a national registry
Presenter: Bruno Vincenzi
Session: ePoster Display
1548P - A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma
Presenter: Mrinal Gounder
Session: ePoster Display
1549P - Pazopanib exposure in advanced soft tissue and bone sarcoma: A pharmacokinetic/pharmacodynamic analysis
Presenter: Marie-Sophie Minot
Session: ePoster Display
1550P - A post hoc analysis of the EPAZ trial: The prognostic role of geriatric variables in elderly soft tissue sarcoma (STS) patients
Presenter: Rainer Hamacher
Session: ePoster Display
1551P - Efficacy of early phase trials for soft-tissue sarcoma patients: The Centre Léon Bérard and Gustave Roussy experience
Presenter: Elise Nassif
Session: ePoster Display
1552P - Magnitude of clinical benefit of cancer drugs used in advanced soft tissue sarcomas and GIST
Presenter: Raul Teres Lleida
Session: ePoster Display
1553TiP - A phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma
Presenter: Christoph Schliemann
Session: ePoster Display